JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
Not yet recruiting · NCT07582822 · Registry updated 2026-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC | Advanced Solid Tumor | Not yet recruiting | Phase 1 | 2026-05-13 | NCT07582822 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biotech Pharmaceutical Co., Ltd. | 8 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henan Cancer Hospital | Zhengzhou | China | 98 |
| Hunan Cancer Hospital | Changsha | China | 87 |
| Nanjing Tianyinshan Hospital | Nanjing | China | 6 |
| Shanghai East Hospital | Shanghai | China | 33 |
| Shanghai Pulmonary Hospital Affiliated to Tongji University | Shanghai | China | 2 |
| Shanxi Cancer Hospital | Taiyuan | China | 25 |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing | China | 38 |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xi'an | China | 14 |
| West China Hospital, Sichuan University | Chengdu | China | 41 |
| Yibin Second People's Hospital | Yibin | China | 5 |
| Zhejiang Cancer Hospital | Hangzhou | China | 84 |